<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Synta Pharmaceuticals Corp. | Company News & Executive Profiles - SNTA | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Synta Pharmaceuticals Corp.]]></description>
	<s:counts start="0" returned="10" found="16" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Synta Pharmaceuticals Corp. Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-360864.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionSafi Bahcall I will now open the call to questions and discussion. Operator? Operator Operator Instructions. Our first question is from Joel Sendek of Lazard Capital Markets.  Joel Sendek - Lazard Capital Markets It appears to me that the biggest risk of the company is that, you...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 04 Nov 2009 12:28:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/value.html"><![CDATA[Value]]></category>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/asset+management.html"><![CDATA[Asset Management]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/operational+planning.html"><![CDATA[Operational Planning]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">SNTA</category>
	</item>
	<item>
		<title><![CDATA[Synta Pharmaceuticals Corp. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-249085.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Our first question comes from the line of Jim Birchenough with Barclays Capital. Jim Birchenough - Barclays Capital Hi, guys, thanks for taking the question. Just on the timelines for the SYMMETRY trial, it seems like a bit of a push out in timelines for...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 13 Nov 2008 12:00:26 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/barclays+plc..html"><![CDATA[Barclays Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/enrollment.html"><![CDATA[Enrollment]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/barclays+plc..html"><![CDATA[Barclays Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/enrollment.html"><![CDATA[Enrollment]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">BCS,SNTA</category>
	</item>
	<item>
		<title><![CDATA[Synta Pharmaceuticals Corp. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-223574.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator instructions our first question comes from the line of Mike King with Rodman & Renshaw   Mike King - Rodman & Renshaw  Hey, good morning. Can you hear me okay?   Safi Bahcall  Yes we can hear you, Mike. ...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 02 Sep 2008 01:08:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">SNTA</category>
	</item>
	<item>
		<title><![CDATA[Synta Pharmaceuticals Corp.'s CEO Safi Bahcall Named Ernst & Young Entrepreneur Of The YearŽ 2008 Award Winner in New England]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_27/ai_n27873717]]></link>
		<description><![CDATA[Safi Bahcall Recognized for Innovation and Breakthrough Developments in Biotechnology/Pharmaceuticals Category  LEXINGTON, Mass. -- Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that its President and Chief Executive Officer, Safi Bahcall, Ph.D. received...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 27 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/entrepreneur.html"><![CDATA[entrepreneur]]></category>
		<category domain="http://resources.bnet.com/topic/entrepreneurship.html"><![CDATA[Entrepreneurship]]></category>
		<category domain="http://resources.bnet.com/topic/ernst+%2526+young+llp.html"><![CDATA[Ernst & Young LLP]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">SNTA</category>
	</item>
	<item>
		<title><![CDATA[Synta Pharmaceuticals Corp. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-226465.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you, Dr. Bahcall. Ladies and gentlemen, we will now be conducting a question-and-answer session. Operator Instructions Thank you. And our first question comes from the line of Mike King with Rodman & Renshaw. Please proceed with your question. Mike King - Rodman & Renshaw Hi, good...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 27 May 2008 09:37:16 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">SNTA</category>
	</item>
	<item>
		<title><![CDATA[Synta Pharmaceuticals Added to NASDAQ Biotechnology Index]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_12/ai_n25405600]]></link>
		<description><![CDATA[LEXINGTON, Mass. -- Synta Pharmaceuticals Corp. (NASDAQ: SNTA), today announced that the Company has been selected for inclusion in the NASDAQ Biotechnology Index NBI, effective as of the market's open on Monday, May 19, 2008.  "We are pleased to be included in the NASDAQ Biotechnology Index," commented Safi Bahcall,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 12 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">NDAQ,SNTA</category>
	</item>
	<item>
		<title><![CDATA[Synta Pharmaceuticals Corp. Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-228999.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you, Dr. Bahcall. Operator Instructions Our first question comes from the line of Mike King with Rodman & Renshaw. Please proceed with your question. Mike King - Rodman & Renshaw Can you hear me? Safi Bahcall Yeah. Mike King - Rodman & Renshaw I am sorry....]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 20 Mar 2008 09:36:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">SNTA</category>
	</item>
	<item>
		<title><![CDATA[Synta Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Jan_29/ai_n24236339]]></link>
		<description><![CDATA[Company to Webcast Presentation on February 7  LEXINGTON, Mass. -- Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 29 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/merrill+lynch+%2526+co.+inc..html"><![CDATA[Merrill Lynch & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MER</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">MER,SNTA</category>
	</item>
	<item>
		<title><![CDATA[Synta Pharmaceuticals Corp. Strengthens Oncology Clinical and Commercial Team]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_April_12/ai_n27200491]]></link>
		<description><![CDATA[New Hires Support STA-4783 Late Stage Development]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 12 Apr 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/team.html"><![CDATA[team]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">SNTA</category>
	</item>
	<item>
		<title><![CDATA[Montgomery & Co. LLC Announces Investment Opinion: Montgomery & Co. LLC Initiates Coverage on Synta Pharmaceuticals Corp]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_March_19/ai_n27184793]]></link>
		<description><![CDATA[SAN FRANCISCO -- Montgomery & Co., LLC, a leading investment bank for growth companies in the information technology, communications, healthcare and media sectors, announced today that Principal and Analyst Shiv S. Kapoor has initiated coverage on Synta Pharmaceuticals Corp. (SNTA - $9.15). Synta is a biopharmaceutical company based in Lexington,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 19 Mar 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/llc.html"><![CDATA[LLC]]></category>
		<category domain="http://resources.bnet.com/topic/synta+pharmaceuticals+corp..html"><![CDATA[Synta Pharmaceuticals Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SNTA</category>
		<category domain="tickers">SNTA</category>
	</item>
</channel>
</rss>
